Wilmington Trust Investment Management’s Gilead Sciences GILD Stock Holding History

Wilmington Trust Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$2.91M	Sell	35,114 -2,000	-5%	-$156K	0.59%	21
2014 Q1	$2.63M	Buy	37,114 +10,200	+38%	+$800K	0.53%	24
2013 Q4	$2.02M	Sell	26,914 -900	-3%	-$62.7K	0.4%	40
2013 Q3	$1.75M	Hold	27,814	–	–	0.37%	45
2013 Q2	$1.43M	Buy	+27,814	New	+$1.45M	0.31%	49

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wilmington Trust Investment Management's GILD Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Gilead Sciences (GILD) stake by 5.4% in Q2 2014, selling an estimated $156K and leaving 35,114 shares worth $2.91M. The position accounts for 0.59% of the portfolio, ranked #21.

Wilmington Trust Investment Management first reported a position in GILD in Q2 2013 and has held it in 5 quarters since. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

Wilmington Trust Investment Management held 35,114 shares of Gilead Sciences worth $2.91M as of Q2 2014.
Wilmington Trust Investment Management sold 2,000 Gilead Sciences shares in Q2 2014, an estimated $156K.
Gilead Sciences made up 0.59% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #21 holding.
Wilmington Trust Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 5 quarters since.
1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.